Betaine activates AMPK and downregulates SREBP-1c, thereby improving hepatic steatosis, while nuciferine, baicalein, puerarin, and emodin also exhibit promising effects in mitigating lipid accumulation through various mechanisms such as inhibiting adipogenic transcription factors or enhancing fatty acid oxidation [24]. The gene discussed is SREBF1; the disease is fatty liver disease.